Comment
. 2002 Sep 5;347(10):768-9; author reply 768-9.
Nonalcoholic fatty liver disease
- PMID: 12214631
Item in Clipboard
Comment
Nonalcoholic fatty liver disease
N Engl J Med.
.
No abstract available
Comment on
-
Nonalcoholic fatty liver disease.N Engl J Med. 2002 Apr 18;346(16):1221-31. doi: 10.1056/NEJMra011775. N Engl J Med. 2002. PMID: 11961152 Review. No abstract available.
Similar articles
-
[Drug therapy for nonalcoholic fatty liver disease].Zhonghua Gan Zang Bing Za Zhi. 2005 Feb;13(2):139. Zhonghua Gan Zang Bing Za Zhi. 2005. PMID: 15727706 Chinese. No abstract available.
-
[News from the Cochrane Library: treatment of nonalcoholic fatty liver disease and steatohepatitis].Z Gastroenterol. 2007 Feb;45(2):191-3. doi: 10.1055/s-2007-962860. Z Gastroenterol. 2007. PMID: 17304406 German. No abstract available.
-
Mechanism of action of metformin in nonalcoholic steatohepatitis.Aliment Pharmacol Ther. 2009 Mar 1;29(5):602-3; author reply 603-4. doi: 10.1111/j.1365-2036.2008.03892.x. Aliment Pharmacol Ther. 2009. PMID: 19183340 No abstract available.
-
Pharmacologic management of nonalcoholic fatty liver disease.Clin Liver Dis. 2004 Aug;8(3):715-28, xii. doi: 10.1016/j.cld.2004.04.011. Clin Liver Dis. 2004. PMID: 15331071 Review.
-
MK-767. Kyorin/Banyu/Merck.Curr Opin Investig Drugs. 2003 Apr;4(4):444-8. Curr Opin Investig Drugs. 2003. PMID: 12808885 Review.
Cited by
-
Development of type 2 diabetes in children and adolescents.Curr Diab Rep. 2006 Jun;6(3):182-7. doi: 10.1007/s11892-006-0032-9. Curr Diab Rep. 2006. PMID: 16898569 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical